Skip to content
Screener

Jade Biosciences JBIO Q3 2025 earnings

Reported November 13, 2025 · Before market open

EPS-$0.48Beat by $0.09
EPS estimate-$0.57

Next report

Aug 12, 2026 (In 2 days)
EPS estimate-$0.66

Financials

Q3 2025

Income statement

See full
Operating income-$27.4M-83.1%
Net income-$25.2M-54.7%
EPS (diluted)-$0.48+90.7%

Balance sheet

See full
Cash & equivalents$50.1M+61.0%
Total debt$867.0K+60.6%
Total equity$179.3M+1,164%
Total assets$202.5M+123%

Cash flow

See full
Operating cash flow-$22.1M-225%
CapEx$57.0K—
Free cash flow-$22.2M—

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$281.57M—
Enterprise value$232.33M—

Returns & leverage

See full
Debt / equity0×—
Current ratio9×+0.2×

FAQ

When did Jade Biosciences report Q3 2025 earnings?
Jade Biosciences (JBIO) reported Q3 2025 earnings on November 13, 2025 before market open.
What were Jade Biosciences's Q3 2025 revenue and EPS?
Jade Biosciences reported eps of $-0.48 for Q3 2025.
Did Jade Biosciences beat estimates in Q3 2025?
EPS beat the consensus estimate of $-0.57 by $0.09.
Where can I find Jade Biosciences's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001193125-25-281498) and the 10-Q periodic report (0001193125-25-281525) directly on SEC EDGAR. The filing index links above go to sec.gov.